Thu, June 1, 2023
Wed, May 31, 2023
Tue, May 30, 2023
Mon, May 29, 2023
Sun, May 28, 2023
Fri, May 26, 2023
Thu, May 25, 2023

Olivia Brayer Reiterated (VRTX) at Buy and Held Target at $365 on, May 30th, 2023

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. buy-and-held-target-at-365-on-may-30th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Olivia Brayer of Cantor Fitzgerald, Reiterated "Vertex Pharmaceuticals Incorporated" (VRTX) at Buy and Held Target at $365 on, May 30th, 2023.

Olivia has made no other calls on VRTX in the last 4 months.



There are 20 other peers that have a rating on VRTX. Out of the 20 peers that are also analyzing VRTX, 6 agree with Olivia's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Increased Target to $305 on, Tuesday, May 2nd, 2023
  • Paul Matteis of "Stifel" Maintained at Hold with Increased Target to $340 on, Tuesday, May 2nd, 2023
  • Brian Abrahams of "RBC Capital" Maintained at Hold with Increased Target to $315 on, Tuesday, May 2nd, 2023
  • Brian Skorney of "Baird" Maintained at Hold with Increased Target to $325 on, Tuesday, May 2nd, 2023
  • Whitney Ijem of "Canaccord Genuity" Maintained at Hold with Increased Target to $312 on, Wednesday, February 8th, 2023
  • Do Kim of "Piper Sandler" Maintained at Hold and Held Target at $296 on, Wednesday, February 8th, 2023


These are the ratings of the 14 analyists that currently disagree with Olivia


  • Christopher Raymond of "Piper Sandler" Initiated at Buy and Held Target at $385 on, Thursday, May 4th, 2023
  • Jason McCarthy of "Maxim Group" Maintained at Strong Buy with Increased Target to $400 on, Wednesday, May 3rd, 2023
  • William Pickering of "Bernstein" Maintained at Buy with Increased Target to $363 on, Wednesday, May 3rd, 2023
  • Jessica Fye of "JP Morgan" Maintained at Buy and Held Target at $345 on, Tuesday, May 2nd, 2023
  • Phil Nadeau of "TD Cowen" Maintained at Buy with Increased Target to $350 on, Tuesday, May 2nd, 2023
  • Robyn Karnauskas of "Truist Securities" Maintained at Strong Buy with Increased Target to $456 on, Tuesday, May 2nd, 2023
  • Colin Bristow of "UBS" Maintained at Strong Buy with Increased Target to $399 on, Tuesday, May 2nd, 2023
  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $380 on, Tuesday, May 2nd, 2023
  • Debjit Chattopadhyay of "Guggenheim" Maintained at Strong Buy with Increased Target to $385 on, Tuesday, May 2nd, 2023
  • Evan Seigerman of "BMO Capital" Maintained at Buy and Held Target at $385 on, Tuesday, May 2nd, 2023
  • Gena Wang of "Barclays" Maintained at Buy with Increased Target to $384 on, Tuesday, May 2nd, 2023
  • Hartaj Singh of "Oppenheimer" Maintained at Buy with Increased Target to $410 on, Tuesday, May 2nd, 2023
  • Jasper Hellweg of "Argus Research" Maintained at Strong Buy with Increased Target to $350 on, Wednesday, March 29th, 2023
  • David Risinger of "SVB Leerink" Maintained at Buy with Decreased Target to $365 on, Wednesday, February 8th, 2023